A simple paper test could offer early cancer diagnosis
The new diagnostic, which is based on analysis of urine samples, could also be designed to reveal whether a tumor has metastasized.
The new diagnostic, which is based on analysis of urine samples, could also be designed to reveal whether a tumor has metastasized.
The printer generates vaccine-filled microneedle patches that can be stored long-term at room temperature and applied to the skin.
In a new study, immunostimulatory drugs slowed tumor growth without producing systemic inflammation.
A new analysis reveals how Staphylococcus aureus gains mutations that allow it to colonize eczema patches.
He conducted groundbreaking research into auditory physiology at MIT and Harvard Medical School, and was the founding director of the Eaton-Peabody Laboratories at Mass Eye and Ear.
Senior Victor Damptey brings his Spanish-speaking abilities to bear as he works toward becoming a physician-scientist.
MIT researchers built DiffDock, a model that may one day be able to find new drugs faster than traditional methods and reduce the potential for adverse side effects.
Researchers develop new, patient-friendly hydrogel platform for administering lifesaving biologics.
Using these RNA-delivery particles, researchers hope to develop new treatments for cystic fibrosis and other lung diseases.
Developed at SMART, the therapy stimulates the host immune system to more effectively clear bacterial infections and accelerate infected wound healing.
Senior Mercy Oladipo is building tools to address disparities in health care.
Using this approach, researchers hope to deliver therapeutic RNA molecules selectively to cancer cells or other target cells.
On March 10 the FDA approved Trofinetide, a drug based on the protein IGF-1. The MIT professor's original research showing that IGF-1 could treat Rett was published in 2009.
Aided by machine learning, scientists are working to develop a vaccine that would be effective against all SARS-CoV-2 strains.
MIT engineers find specialized nanoparticles can quickly and inexpensively isolate proteins from a bioreactor.